The 13th Annual IBA World Life Sciences Conference addresses global legal, regulatory and intellectual property developments shaping the life sciences sector including clinical research, innovation, and healthcare integration
Key Topics
Global clinical trial trends and regulatory outlook
EU pharmaceutical framework, data exclusivity and Bolar provisions
Antitrust issues and intellectual property strategies in pharma
Legal aspects of preventive healthcare and longevity innovation
Cross-border intellectual property disputes and enforcement
Integration of pharmaceuticals and medical technologies within healthcare systems
Accountability frameworks in open science and collaborative research
Regulatory challenges for combination drug-device products
WIPO GRATK Treaty implications for intellectual property protection
Who should Attend
Life sciences legal professionals and attorneys
Pharmaceutical and biotechnology executives
Intellectual property and patent specialists
Regulatory affairs and compliance experts
Healthcare policy advisors and consultants
In-house counsel in pharma and MedTech companies
Researchers involved in clinical and open science initiatives
